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Aims. Our aim is to investigate, in 13 cases (delivering preterm) and 21 matched (for age, parity, and gestational age) controls (de-
livering at term), whether midtrimester amniotic ﬂuid concentrations of elastase, secretory leukocyte proteinase inhibitor (SLPI),
soluble intercellular adhesion molecule-1, and soluble vascular cell adhesion molecule predict asymptomatic intra-amniotic in-
ﬂammation/infection and preterm labor. Results. Concentrations of all substances were not statistically diﬀerent among mothers,
delivering preterm or at term. SLPI concentrations signiﬁcantly increased in women, going into labor without ruptured mem-
branes, irrespective of pre- or term delivery (P<. 007, P<. 001, resp) and correlated with elastase (r = 0.508, P<. 002).
Conclusions. Midtrimester amniotic ﬂuid SLPI concentrations signiﬁcantly decrease when membrane rupture precedes pre- or
full-term labor. However, none of the investigated substances predict preterm delivery.
Copyright © 2006 Ariadne Malamitsi-Puchner et al.. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
INTRODUCTION
Preterm birth is due to several causes, among which a preex-
isting—occasionally asymptomatic—intrauterine infection
relatively early in pregnancy should be considered [1–3].
Thus, amniotic ﬂuid microbial invasion [1, 2, 4, 5] and/or el-
evated levels of proinﬂammatory cytokines, chemokines, or
otherimplicatedmolecules[3,4,6,7]shouldbeinvestigated.
Elastase, a protease produced by neutrophils, histiocytes,
and macrophages, is stored in cytoplasmic granules and is
secreted during cell activation. It targets at the degradation
of intra- or extracellular proteins, among which elastin, col-
lagen, and ﬁbronectin [8, 9] are included. Main inhibitor of
elastaseisthesecretoryleukocyteproteinaseinhibitor(SLPI),
presentin thesecretions oftherespiratoryandgenitalsystem
[10–12]. It has been shown that SLPI limits the proinﬂam-
matorycascadesongoingduringparturition,protectsagainst
microbial invasion and the response to infection [13], and
inhibits the proinﬂammatory action of bacterial products,
for instance of lipopolysaccharides [14, 15]. In general, pro-
tease inhibitors, by controlling extracellular matrix proteoly-
sis, contribute to tissue homeostasis [16].
Increased elastase concentrations have been documented
at the site of ruptured membranes in cases of preterm de-
livery [17]. The ratio of elastase to SPLI concentrations is
important for the evolution of a normal delivery, as SPLI
seems to protect both fetal membranes and cervical tissue
[12].
Adhesion molecules (soluble intercellular adhesion mol-
ecule(sICAM-1)andsolublevascularcelladhesionmolecule
(sVCAM-1)) are members of the cell-surface immunoglob-
ulin superfamily of adhesion receptors [18] expressed on
haematopoietic and nonhaematopoietic cell surfaces, par-
ticularly on endothelial cells [19] and induced or upregu-
lated by proinﬂammatory cytokines (eg, interleukin-1, tu-
mor necrosis factor α, interferon-γ)[ 20, 21]. As they medi-
atetheadhesionoflymphocytes,monocytes,andeosinophils
on activated endothelium, they enable circulating white cells
to enter inﬂamed tissues [22, 23], and thus they are used
as markers of inﬂammation or tissue damage [24]. Both
molecules exist in transmembrane and soluble (s) forms
[25, 26].
This study was based on the hypothesis that ele-
vated midtrimester amniotic ﬂuid concentrations of elas-
tase, sICAM-1, sVCAM-1, and decreased levels of SLPI (all
four substances are implicated in the inﬂammatory process)
could possibly serve as useful predictors of asymptomatic
intra-amnioticinﬂammationand/orinfection,eventuallyre-
sulting in preterm labor and delivery. Therefore, we aimed
to determine the above substances in the amniotic ﬂuid2 Mediators of Inﬂammation
Table 1: Demographic data of participating women delivering at < 37 weeks of gestation (cases) or at term (controls) (mean ± SD).
Cases (n = 13) Controls (n = 21) P value
Age (y) 38.0( ±1.1) 37.1( ±0.7) .50
Gestational weeks at
amniocentesis 18.5( ±0.6) 17.4( ±0.3) .07
Body mass index 25.5( ±1.8) 22.5( ±0.9) .12
Gender of oﬀspring — — .63
Male 7 (53.8%) 13 (61.9%) —
Female 6 (46.2%) 8 (38.1%) —
of women, undergoing second trimester amniocentesis and
subsequently delivering pre- or full-term infants.
MATERIAL AND METHODS
Three hundred and twelve women at the second trimester of
pregnancy underwent ultrasound—guided transabdominal
amniocentesis for several reasons (advanced maternal age,
nuchal translucency of the fetus, family history of congeni-
tal anomalies, parental hemoglobinopathies). These women
belonged to a low-risk pregnancy group, as stated by their
private obstetricians, who followed them on a regular ba-
sis. Out of the total 312 women, 13 subsequently progressed
to spontaneous preterm delivery before 37 weeks of gesta-
tion, 6 with and 7 without rupture of membranes. The above
13 women were matched for maternal age, parity, and ges-
tational age at amniocentesis (within 2 weeks) with all el-
igible controls (21 out of the initial 312 women), who de-
livered at 37 weeks of gestation or later healthy, appropriate
for gestational age neonates (all with birth weights between
the 30th and70th customized centile-controlling for mater-
nal height, booking weight, ethnic group, parity, gestational
age, birth weight, and neonatal gender) [27]. Premature rup-
ture of membranes, deﬁned as leaking of amniotic ﬂuid be-
fore the onset of labor, was absent in 12 and present in 9 out
of these 21 controls with term delivery.
Women with multiple pregnancy, cervical dilatation (>
1cm), or ruptured membranes at the time of amniocen-
tesis, abnormal fetal karyotype, or major fetal anomalies
were excluded. All included in this study cases and controls
were nonsmokers and did not report a previous preterm
delivery. Neither clinical signs of chorioamnionitis (tem-
perature ≥ 37.8◦C, uterine tenderness, malodorous vagi-
nal discharge, fetal tachycardia > 160beats/min, maternal
tachycardia > 100beats/min, and maternal leucocytosis >
15000cells/mm3) nor bleeding during pregnancy was re-
ported. Demographic data of the participating women are
shown in Table 1. The Ethical Committee of our teaching
hospitalapprovedthecollectionandtheuseofthesesamples.
Written informed consent was obtained from all subjects in-
cluded in the study.
Drawn amniotic ﬂuid was centrifuged and stored in
polypropylene tubes at −80◦C until assay. Levels of all
substances were determined by commercially available
enzyme-linked immunosorbent assays: polymorphonuclear
(PMN) elastase, by Immundiagnostik AG (D-64625, Ben-
sheim),humanSLPI,humansICAM-1,andhumansVCAM-
1, R&D Systems Inc. (Minneapolis, Minn 55413, USA). Sen-
sitivity, intra- and interassay coeﬃcients of variation for
PMN elastase were < 0.12ng/mL, 7.5% and 8.4%; for SPLI
< 25pg/mL, 4.5% and 6.2%; for sICAM-1 0.35ng/mL, 3.5%
and5.9%;andforsVCAM-12ng/ml,6.3%and8.2%,respec-
tively.
As data from all four substances were normally dis-
tributed (Kolmogorov-Smirnov test), t test was applied for
the comparison of investigated amniotic ﬂuid substances be-
tween pre- and full-term pregnancies. Nonparametric tests
were applied for the comparisons between intact and rup-
tured membranes in each group. P<. 05 was considered
statistically signiﬁcant. A receiver-operating characteristic
(ROC) curve was used to identify cutoﬀ concentrations of
amniotic ﬂuid elastase, SPLI, sICAM-1, and sVCAM-1 for
spontaneous preterm delivery after midtrimester amniocen-
tesis.
RESULTS
Table 2 presents mean values and standard errors for all
four determined substances. PMN elastase, sICAM-1, and
sVCAM-1 levels were higher and SLPI levels were lower
in second-trimester amniotic ﬂuid of mothers delivering
preterm as compared to mothers delivering at term, how-
ever, these ﬁndings did not reach statistical signiﬁcance. In
contrast, SLPI levels in second-trimester amniotic ﬂuid were
signiﬁcantly higher in the group of women who delivered ei-
ther preterm (P<. 007) or at term (P<. 001) with absence
of ruptured membranes prior to delivery (see Figure 1). Fur-
thermore, a statistical signiﬁcant correlation existed between
elastase and SPLI (r = 0.508, P<. 002).
ROC curve analysis of delivery at < 37 weeks for vari-
ous cutoﬀ levels of elastase, SLPI, sICAM-1, and sVCAM-
1w a sp e r f o r m e d .T h eb e s tc u t o ﬀ point for elastase was a
concentration of 5.72ng/mL (sensitivity 53.8%, speciﬁcity
57.14%, odds ratio(OR)1.6, 95% conﬁdenceinterval (CI) =
0.4-6.3), for SPLI a concentration of 56.5ng/mL(sensitivity
53.8%, speciﬁcity 42.86%, OR = 0.9, 95% CI = 0.2-3.5),
forsICAM-1 a concentrationof 116ng/mL, (sensitivity 62%,
speciﬁcity 62%, OR 2.6, 95% CI: 0.6-10.8), and for sVCAM-
1 a concentration of 290μg/dL, (sensitivity 76.9%, speciﬁcity
57.1%, OR 4.4, 95% CI = 0.9-21).Ariadne Malamitsi-Puchner et al. 3
Table 2: Mean values and standard errors (SE) for each determined substance.
Cases (n = 13) Controls (n = 21) P value
Mean SE Mean SE
PMN elastase (ng/mL) 7.31 .65 .50 .7 <. 23
SLPI (ng/mL) 65 6.66 3 3 .7 <. 83
sICAM-1 (ng/mL) 194 40 115 10.5 <. 08
sVCAM-1 (ng/mL) 309 15 293 9.5 <. 34
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Figure 1: Levels of SLPI in women, who delivered either preterm (a) or at term (b) with intact membranes (a) n = 7 and (b) n = 12 or
premature rupture of membranes (PROM) (a) n = 6 and (b) n = 9, respectively.
DISCUSSION
In this study we prospectively determined midtrimester am-
niotic ﬂuid concentrations of several factors and related
their levels with pregnancy outcome. Our results indicate
that even from the early second trimester of pregnancy, in
pretermorfull-termdeliveries,precededbyruptureofmem-
branes,levelsofSLPIaresigniﬁcantlydecreased,possiblyim-
plying inﬂuence of the latter on membrane integrity.
Previous studies have reported that amniotic ﬂuid pro-
tease inhibitors [alpha 1-protease inhibitor (α1-PI), urinary
trypsine inhibitor, and SLPI] control elastase activity [12, 13,
28, 29]. In this respect, amniotic ﬂuid concentrations of α1-
PI have been found lower in women with rupture of mem-
branes [28]. In addition, Zhang et al [30] reported that SLPI
functions as a potent anti-inﬂammatory agent by interfering
with the signal transduction pathway leading to production
of monocyte matrix metalloproteinases, which are also im-
plicated in membrane rupture. On the other hand, the ad-
verse eﬀects of elastase on the growth and properties of elas-
tic tissue in the amnion of rabbits have been demonstrated
[31]. Relatively, immunohistochemical studies of fetal rup-
turedmembraneshaveshownaccumulationofelastaseatthe
ruptured site both in full- and preterm deliveries [32, 33].
Amniotic ﬂuid neutrophils are of fetal origin and ac-
cumulation of elastase in the amniotic ﬂuid could reﬂect
fetalinﬂammatoryresponse,asithappenswithrespectivein-
crease of metalloproteinase 8 [17] .R e l a t i v e l y ,ap o s i t i v ec o r -
relation of elastase with interleukin-6 has been previously re-
ported [34]. A possible explanation for the lower SLPI con-
centrations in cases of ruptured membranes is its consump-
tion early in pregnancy during repeated inﬂammatory pro-
cesses. On the other hand, the determination in the amni-
otic ﬂuid of elastase both in pre- and full-term delivery could
imply that this substance is part of the common metabolic
pathway of labour ,and therefore its concentrations did not
change signiﬁcantly in both groups of the study.
Concerning adhesion molecules, previous studies
have shown that increased circulating sICAM-1 levels in
midtrimester amniotic ﬂuid are related to a shortened length
of gestation at delivery [35], that intercellular adhesion
molecule-1 concentration, in utero, decreases after antibi-
otic treatment [36] and that determination of sICAM-1,
expressed on fetal membranes and mononuclear cells of am-
niotic ﬂuid, may be a valuable biomarker for early detection
of acute chorioamnionitis and the possibility of premature
rupture of membranes [37]. Nevertheless, another study
states that in contrast to other proinﬂammatory molecules
(interleukin-6 and leukocyte adhesion molecule-1), amni-
otic ﬂuid sICAM-1 concentrations were not signiﬁcantly
diﬀerent between patients with intra-amniotic infection
than without intra-amniotic infection [38], a ﬁnding being4 Mediators of Inﬂammation
in accordance with the relevant result of the present study,
referring to incidence of preterm delivery.
Lastly, to the best of our knowledge, no study could
be found determining amniotic ﬂuid concentrations of
sVCAM-1 in midtrimester.
In conclusion, second-trimester amniotic ﬂuid SLPI lev-
elsaresigniﬁcantlydecreasedincaseswherepre-orfull-term
delivery is preceded by membrane rupture. Therefore, SLPI
concentrations in the amniotic ﬂuid obtained by second-
trimester amniocentesis could possibly predict the rupture
of membranes either in the second or in the third trimester.
In contrast, based on this study, midtrimester amniotic ﬂuid
elastase, SLPI, sICAM-1, and sVCAM-1 concentrations are
not helpful in predicting preterm delivery.
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